Current Opinion in Infectious Diseases

Papers
(The TQCC of Current Opinion in Infectious Diseases is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)
ArticleCitations
Invasive aspergillosis in coronavirus disease 2019: a practical approach for clinicians47
Strongyloidiasis-related lung involvement: too much of a bad thing45
Potential opportunities and challenges for infection prevention and control for cystic fibrosis in the modern era41
Postexposure prophylaxis for occupational exposure to selected pathogens for healthcare personnel39
Editorial introductions37
Hematopoietic stem cell transplantation and cellular therapy in persons living with HIV36
Skin and soft tissue infections in the elderly34
From diagnosis to management: current perspectives on congenital cytomegalovirus infection31
Surgical management of cystic echinococcosis of the liver29
Corticosteroids for viral central nervous system infections29
Complexities of cardiomyopathy in septic shock28
Long and persistent COVID-19 in patients with hematologic malignancies: from bench to bedside27
La Crosse virus encephalitis in children27
Immunocompromised host section: Adoptive T-cell therapy for dsDNA viruses in allogeneic hematopoietic cell transplant recipients26
Fusarium species central nervous system infection25
New therapies for nontuberculous mycobacterial lung infection25
Progress and challenges in human papillomavirus and cervical cancer in southern Africa24
Bacterial cholesterol-dependent cytolysins and their interaction with the human immune response24
Typhoid fever control in the 21st century: where are we now?24
Babesiosis in immunosuppressed hosts: pathogenesis, diagnosis and management23
Mycobacterial skin infection22
Viral meningitis and encephalitis: an update22
Malaria in pregnancy: baby steps21
Tuberculosis molecular bacterial load assay in the management of tuberculosis21
Mpox in people living with HIV21
Methicillin-resistant Staphylococcus aureus lung infection in coronavirus disease 2019: how common?21
Tick-borne encephalitis20
Follow-up blood culture in Gram-negative bacilli bacteraemia: for whom is follow-up blood culture useful?20
The reemergence of Streptococcus pyogenes in skin and soft tissue infections: a review of epidemiology, pathogenesis, and management strategies20
Resistant herpes simplex virus infections – who, when, and what's new?20
Does climate change threaten delivery of HIV care in resource-limited settings?18
Mitigation of nontuberculous mycobacteria in hospital water: challenges for infection prevention18
Appropriate surgical management in skin and soft tissue infections18
Management of neonates born to mothers with active genital herpes simplex virus infection: an alternative approach18
Editorial introductions17
Diagnostic approach and update on encephalitis17
Gut microbiome and its clinical implications: exploring the key players in human health16
CMV antiviral stewardship in transplantation – the next frontier16
Diagnostic stewardship: what impacts antibiotics use?16
Using antibiotics wisely16
New diagnostic strategies to distinguish Crohn's disease and gastrointestinal tuberculosis16
The plumbing problem: rising antimicrobial resistance in building water systems16
The impact of coronavirus disease 2019 on people with HIV15
Drivers of melioidosis endemicity: epidemiological transition, zoonosis, and climate change15
Large lessons learned from small vessels: coronary microvascular dysfunction in HIV15
Update on the treatment of chronic pulmonary aspergillosis15
Immunotherapeutic approaches to HIV cure and remission15
Prenatal and postnatal antiviral therapies for the prevention and treatment of congenital cytomegalovirus infections14
How to differentiate skin rash in covid, mononucleosis, chickenpox, sixth disease and measles14
The microbiota in respiratory tract infections: from association to intervention13
Risk stratification for selecting empiric antibiotherapy during and after COVID-1913
Respiratory syncytial virus in children: epidemiology and clinical impact post-COVID-1912
Respiratory syncytial virus prevention in immunocompromised hosts: gaps and opportunities12
New trends in congenital syphilis: epidemiology, testing in pregnancy, and management12
Editorial: Pathogenesis and immune response – editorial12
The secret weapon to reduce multidrug-resistant Gram-negative infections: can vaccines help decrease MDR risk?12
Childhood tuberculosis12
Editorial introductions12
Interpreting and managing preservation fluids positive for Gram-negative bacteria12
Human adenovirus lung disease: outbreaks, models of immune-response-driven acute lung injury and pandemic potential12
The role of macrolides in severe community-acquired pneumonia and the potential impact of macrolide-resistant Mycoplamsa pneumoniae12
Short treatment duration for community-acquired pneumonia11
An overview of risk factors, management and prevention of cochlear implant infections11
Respiratory metagenomics: route to routine service11
Emerging treatment options for skin and soft tissue infections tailoring drug selection to individual patients11
H5 and H9 avian influenza – potential re-emergent zoonotic threats to humans11
Antibiotic therapy for nonfermenting Gram-negative bacilli infections: future perspectives11
Data science for pediatric infectious disease: utilizing COVID-19 as a model10
Emerging infections in vulnerable hosts: Stenotrophomonas maltophilia and Elizabethkingia anophelis10
Short-course antibiotic strategies for ventilator-associated pneumonia10
Travellers’ diarrhoea – solidifying our knowledgebase10
A new era of HIV care for age-associated multimorbidity10
The disease burden of respiratory syncytial virus in Infants10
The microbiome as a biomarker of anal precancerous lesions in people with HIV10
Update on drug treatments for multidrug resistant tuberculosis10
Neurobrucellosis10
Updates on the neurological manifestations of SARS-CoV-2 infection9
Endemic, epidemic and pandemic infections: the roles of natural and acquired herd immunity9
Burden of influenza in the elderly: a narrative review9
The role of Gram-negative bacteria in skin and soft tissue infections9
Latent tuberculosis screening and treatment in solid organ and hematopoietic stem cell transplant candidates and recipients9
Pneumocystis jirovecii in solid organ transplant recipients: updates in epidemiology, diagnosis, treatment, and prevention9
Novel techniques in the treatment of skin and soft tissue infection9
Skin and soft tissue infections in solid organ transplants9
Genome-wide approaches to bacterial strain typing: a history and review of recent methodological advances9
Identifying patients with difficult-to-treat acute bacterial skin infections9
Resurgence of Mycoplasma pneumoniae infections in children: emerging challenges and opportunities9
Urinary tract infections in immunocompromised patients9
0.060434818267822